Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
August 2007
Features
Gastric Acid Suppression by Proton Pump Inhibitors as an Independent Risk Factor for Clostridium difficile–Associated Diarrhea
In a study that examined whether PPIs were associated with the development of CDAD in hospitalized patients, the authors found that PPIs did not raise the incidence of this disease, which is caused by a prevalent bacterial infection.
Keithen Branch, PharmD, Vince Yahl, PharmD, BCPS, Karen Kier, PhD, MSc, BSPharm, Nancy Mertz, BBA, and Suzanne Marques, PharmD, BCPS
Meeting Highlights
American Thoracic Society, Digestive Disease Week 2007, and American Society of Hypertension
Sessions from three meetings included discussions of arformoterol and indacaterol for chronic obstructive pulmonary disease, pegylated interferon with or without ribavirin and its role in hepatitis C virus infection, ambrisentan for pulmonary arterial hypertension, and olmesartan/amlodipine combinations for hypertension.
Reuben B. David
Cover Story
Strategies for Treating Colorectal Cancer at Various Stages
The author presents a detailed account of the causes, diagnosis, prognosis, and therapies for colorectal cancer, including some promising biologic agents under development.
Marvin M. Goldenberg, PhD, RPh, MS
Book Review
Health Care Regulation in America: Complexity, Confrontation, and Compromise
Author: Robert I. Field, JD, MPH, PhD
Reviewed by Sara Thier, MPH
Departments
Editorial
Not Again!
David Nash, MD, MBA, describes the effectiveness of various interventions in the uphill battle to motivate patients to comply with prescribed medication regimens.
David Nash, MD, MBA
Medication Errors
Mix-ups with “Medrols”
Matthew Grissinger, RPh, FASCP, shows how easy it is to confuse methylprednisolone acetate (Depo-Medrol) with methylprednisolone sodium succinate (Solu-Medrol).
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Pharmacies Dislike New Medicaid Reimbursement Formula for Generic Drugs
Stephen Barlas discusses a new Medicaid rule that may result in lower reimbursements to pharmacies for popular generic drugs.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
P&T presents the latest studies and information about FDA approvals, drug indications, and industry updates.
Drug Forecast
Ramelteon (Rozerem): A Novel Treatment Option for Patients with Insomnia
Drs. Sherwood, Rey, and Conwell review ramelteon (Rozerem) for patients with insomnia.
Devon A. Sherwood, PharmD, Jose A. Rey, PharmD, BCPP, and Michelle R. Conwell, PharmD
